Mezzion Pharma Co.,Ltd. (KOSDAQ: 140410)

Mezzion Pharma Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	23,122	40,246	29,399	24,210	35,854	15,644
Short-Term Investments	18,000	18,000	3,000	23,284	13,250	20,500
Trading Asset Securities	-	-	-	-	-	5,015
Cash & Short-Term Investments	41,122	58,246	32,399	47,494	49,104	41,159
Cash Growth	-37.68%	79.78%	-31.78%	-3.28%	19.30%	-31.86%
Accounts Receivable	1,131	2,309	2,644	2,368	2,565	2,867
Other Receivables	857.14	2,154	238.76	377.57	223.51	281.5
Receivables	2,598	5,925	4,203	4,435	4,248	4,200
Inventory	5,521	5,742	8,835	11,777	7,011	6,003
Prepaid Expenses	142.58	136.44	265.05	266.77	238.94	252.15
Other Current Assets	7,523	4,194	195.28	201.3	66.81	235.1
Total Current Assets	56,907	74,244	45,897	64,174	60,669	51,849
Property, Plant & Equipment	2,989	2,854	4,245	4,879	5,899	4,902
Long-Term Investments	2.29	7.46	-	-0	0	-0
Other Intangible Assets	1,620	1,620	1,620	1,620	1,620	1,620
Long-Term Deferred Charges	14,936	11,324	-	12,559	6,622	-
Other Long-Term Assets	926.16	1,951	1,950	672.93	656.16	472.46
Total Assets	77,480	92,149	54,022	83,935	75,625	58,874
Accounts Payable	1,869	4,030	7,173	5,503	3,466	3,574
Accrued Expenses	18,547	-	-	7,188	5,533	7,850
Short-Term Debt	-	499.58	1,063	932.01	985.5	424.62
Current Portion of Leases	732.03	-	-	1,051	1,015	753.33
Current Income Taxes Payable	-	-	-	-	803.65	76.95
Other Current Liabilities	342.52	25,086	17,844	3,823	3,711	831.08
Total Current Liabilities	21,491	29,615	26,080	18,497	15,514	13,510
Long-Term Leases	-	-	-	2,338	3,104	2,420
Other Long-Term Liabilities	915.46	1,090	1,702	89.78	88.78	0
Total Liabilities	22,406	30,705	27,782	21,141	18,816	16,044
Common Stock	14,912	14,804	13,371	4,451	4,446	4,353
Additional Paid-In Capital	157,679	150,510	99,256	107,802	107,530	82,963
Retained Earnings	-125,235	-123,723	-111,052	-74,789	-61,166	-47,351
Comprensive Income & Other	7,717	19,854	24,665	25,330	5,999	2,865
Shareholders' Equity	55,074	61,444	26,240	62,793	56,810	42,830
Total Liabilities & Equity	77,480	92,149	54,022	83,935	75,625	58,874
Total Debt	732.03	499.58	1,063	4,321	5,104	3,597
Net Cash (Debt)	40,390	57,747	31,336	43,173	44,000	37,562
Net Cash Growth	-35.78%	84.28%	-27.42%	-1.88%	17.14%	-37.57%
Net Cash Per Share	1362.13	2044.93	1172.20	1617.75	1692.10	1446.12
Filing Date Shares Outstanding	29.42	29.61	26.74	26.7	26.68	26.12
Total Common Shares Outstanding	29.42	29.61	26.74	26.7	26.68	26.12
Working Capital	35,416	44,628	19,817	45,678	45,155	38,339
Book Value Per Share	1872.02	2075.31	981.23	2351.55	2129.45	1639.88
Tangible Book Value	53,454	59,825	24,620	61,174	55,190	41,210
Tangible Book Value Per Share	1816.97	2020.60	920.66	2290.89	2068.74	1577.86
Buildings	-	-	23.97	23.97	7.97	-
Machinery	-	1,976	3,523	2,908	2,652	2,684
Construction In Progress	-	619.69	439.17	193.43	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.